Anthony Joshua's win vs Andy Ruiz Jr was 'meaningless'; Tyson Fury is now the favourite, says Carl Froch

14 April 2020

Must read

standard.co.uk

Carl Froch believes Anthony Joshua’s rematch win against Andy Ruiz Jr was “meaningless”, stating the heavyweight champion still has serious weaknesses.

» Read More

'We will bounce back': Rishi Sunak warns 'tough times' lie ahead but UK economy will survive Covid-19 crisis

Spanish football shutdown: RFEF plans to fast-track lower leagues when season resumes after coronavirus

Germany ranks as the worst G10 nation for real wage growth with UK sitting mid-table

Government needs to take action as 80% of UK drivers won’t buy electric vehicles due to rise in electricity costs

EverCraft Ecotechnologies creates future market with innovative solution from ecoCNTs

Unilever raises full-year sales forecasts after price hike

What is an after dinner speaker and what do they do

Germany ranks as the worst G10 nation for real wage growth with UK sitting mid-table

Government needs to take action as 80% of UK drivers won’t buy electric vehicles due to rise in electricity costs

EverCraft Ecotechnologies creates future market with innovative solution from ecoCNTs

Unilever raises full-year sales forecasts after price hike

What is an after dinner speaker and what do they do

Anthony Joshua's win vs Andy Ruiz Jr was 'meaningless'; Tyson Fury is now the favourite, says Carl Froch

Must read

Study reveals hidden mental health symptoms in people with autoimmune diseases

Large dusty clumps around young star provide insight into how planets are born

Can You Really Offset Your Carbon Footprint From Flying?

Michael Gove: Labour energy policy would ‘give jobs to Russian workers’

Latest article

Study reveals hidden mental health symptoms in people with autoimmune diseases

Large dusty clumps around young star provide insight into how planets are born

Can You Really Offset Your Carbon Footprint From Flying?

Michael Gove: Labour energy policy would ‘give jobs to Russian workers’

New immunotherapy drug shows promise as cancer treatment, research suggests